Results 51 to 60 of about 67,294 (321)

Multimodal imaging in constrictive pericarditis: a case report of cardiac cirrhosis [PDF]

open access: yes, 2023
Constrictive pericarditis is a rare cause of ascites and cardiac cirrhosis. We present the case of a 36-year- old male patient with a history of cirrhosis of unknown etiology, who consulted for refractory ascites, dyspnea, and lower limb swelling ...
Baltodano-Arellano, Roberto   +6 more
core   +1 more source

Constrictive Pericarditis as an Initial Manifestation of Systemic Lupus Erythematosus

open access: yesCureus, 2020
A young female presented with new-onset rash, oral ulcers and dyspnea without overt features of heart failure. She was diagnosed with systemic lupus erythematosus with early constrictive pericarditis, cutaneous lupus and serositis in the form of ...
Samiksha Gupta   +4 more
semanticscholar   +1 more source

Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners. [PDF]

open access: yes, 2017
Systemic sclerosis (SSc) is a rare disabling autoimmune disease with a similar mortality to many cancers. Two randomized controlled trials of autologous hematopoietic stem cell transplantation (AHSCT) for SSc have shown significant improvement in organ ...
A Gabrielli   +81 more
core   +5 more sources

Constrictive pericarditis following Coronary Artery Bypass Grafting

open access: yesIndian Heart Journal, 2013
Constrictive pericarditis following Coronary Artery Bypass Surgery is an uncommon disorder. We report a patient who developed constrictive pericarditis after Coronary Artery Bypass Grafting.
Anirban Kundu   +2 more
doaj   +1 more source

A Complicated Case of Transient Constrictive Pericarditis Secondary to Rivaroxaban-Associated Hemopericardium

open access: yesJACC: Case Reports, 2020
A 72-year-old man on rivaroxaban developed effusive constrictive pericarditis secondary to hemopericardium. His condition improved with anti-inflammatory therapy supporting a diagnosis of transient constrictive pericarditis.
Vardhmaan Jain, MD   +6 more
doaj  

ETIOLOGY, INVESTIGATIONS, AND TREATMENT IN CASES OF CONSTRICTIVE PERICARDITIS [PDF]

open access: yes, 2022
The fibroelastic sac that covers the heart is known as the pericardium. It has an effect on cardiac hemodynamics and serves as a protective barrier. Constrictive pericarditis is a condition in which the pericardium grows granulation tissue, causing a ...
ABD AL-RAZIK, ASHRAF HAMADA   +5 more
core   +1 more source

A difficult diagnosis - constrictive pericarditis and its treatment: a case report [PDF]

open access: yes, 2011
RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.
Altaf, Syed Y   +5 more
core   +2 more sources

Constrictive tuberculous pericarditis in a HIV-positive patient [PDF]

open access: yes, 2017
Constrictive pericarditis is a relatively rare clinical manifestation nowadays. We present the case of an HIV-positive patient with constrictive calcified pericarditis due to an infection with Mycobacterium tuberculosis.
Balmer, Mary-Claude   +3 more
core  

Transient Constrictive Pericarditis after Coronary Bypass Surgery [PDF]

open access: yes, 2011
Constrictive pericarditis is a rare complication after coronary artery bypass grafting In most cases pericardiectomy is required as a definitive treatment.
Choi, Sae-Young   +3 more
core   +2 more sources

Atrial Fibroblasts‐Derived Extracellular Vesicles Exacerbate Atrial Arrhythmogenesis

open access: yesAdvanced Science, EarlyView.
Exosome miR‐224‐5p derived from angiotensin II‐treated atrial fibroblasts creates a substrate for AF by promoting atrial electrical remodeling. Increased exosome miR‐224‐5p enhances AF susceptibility by inhibiting CACNA1c expression and decreasing ICa current of atrial cardiomyocytes.
Yue Yuan   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy